ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,479.44
0.11%
US Tech 100
19,414.40
0.06%
다우존스 지수
38,813.70
0.09%
Bitcoin
64,691.03
-2.70%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Edge Therapeutics, Inc. (EDGE)

  7. Edge Therapeutics, Inc. (EDGE) 뉴스

EDGE

EDGE THERAPEUTICS, INC. (EDGE)

Edge Therapeutics, Inc.
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:EDGE
일자시간출처헤드라인심볼기업
2019/03/1907:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1906:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1906:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1906:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1906:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1906:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1906:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1906:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1906:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1906:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1906:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1820:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/1606:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/0907:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/0507:30Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/0507:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/03/0507:25Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/2607:03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/2307:23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/2206:21Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/2205:36Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/2120:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/2120:15GlobeNewswire Inc.Edge Therapeutics Announces Full Year 2018 Financial ResultsNASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/1604:35Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/1520:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/1401:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/1201:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/0507:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/02/0507:10Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
2019/01/3107:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
 검색 관련기사 보기:NASDAQ:EDGE

최근 히스토리

BIT
P1PM41
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유